Join Intelligent Health AI this Friday at 11am BST as we reveal the 3rd episode of our Going Viral webinar series: Long term implications of health data use in the response to COVID-19.

We're excited to announce that the Novartis Foundation will be returning as Headline Sponsor for the third consecutive year. In addition, Microsoft will join as Lead Technology Sponsor, cementing Intelligent Health as the annual meeting place of the global artificial intelligence and medicine community. 

This year again, over 3,500 healthcare and technology professionals from all over the world will gather in Basel, Switzerland, to work together and help create a future where AI will revolutionize health and #saveliveswithai. 

Following the huge success of Intelligent Health’s free debut webinar last week, we are pleased to announce an exciting follow up this week for our UK community!

Future proofing the NHS - How technology is going to play a role in the reaction to COVID-19 within the NHS and how clinicians can deploy technology/telemedicine at pace and scale in response to the ongoing crisis.

Intelligent Health has never shied away from the big discussions and it’s time we address the biggest disruptor the world has faced in a generation, COVID-19.

The Intelligent Health community is comprised of over 52,000 multidisciplinary experts and we will be opening the discussion floodgates this Thursday 12th March at 2pm GMT - Going Viral: Keeping Calm in the Face of COVID-19.

“Machines will not replace physicians, but physicians using AI will soon replace those not using it.” - Antonio Di Leva, The Lancet

Following our pre-event Q&A with headline speaker Frank Hester OBE, I had the opportunity to sit down with Frank and delve a little further into what TPP’s mission is and where he sees the unexplored opportunities and potential misconceptions surrounding AI in Healthcare.

Algocyte® is an end-to-end remote health monitoring. A medically-driven solution for patient blood testing with
advanced visualisation tools for longitudinal analysis and medical decision support. Algocyte® is a state-of-the-art A.I. and proprietary technology combined in a unique end-to-end healthcare platform for remote blood testing, monitoring and predictive analytics.

We spoke to some of the brains behind Alpha Health, a long term innovation facility created by Telefonica in 2016 to work on moonshot projects. Ollie, Strategy Director and Tarek, Chief Behavioural Officer, give us their thoughts on AI in medicine ahead of their presentation and interactive challenge session. 

Ahead of Intelligent Health UK 2020, we interviewed a pioneer of revolutionary new clinical software. TPP Founder & CEO, Frank Hester OBE discussed AI in healthcare ahead of his headline presentation: Maximising our digital infrastructure for a 21st-century workforce. 

We're pleased to announce that the Accelerated Access Collaborative (AAC), NHSX and the National Institute for Health Research (NIHR) will be at Intelligent Health UK next week to provide you with the first advice clinic to answer any questions you might have on the application process for the Artificial Intelligence in Health and Care Award.

£140 million will be available over three years to accelerate the testing and evaluation of the most promising AI technologies which meet the strategic aims set out in the NHS Long Term Plan. 

"We don’t want to beat radiologists. We want to beat cancer." 

Hear from the Healthtech entrepreneur pioneering AI in Radiology to detect breast cancer earlier. We interviewed Kheiron Medical CEO Peter Kecskemethy ahead of his presentation: AI for breast screening - a report from the trenches: Delivering practical value to the NHS.